Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|May 11, 2012
Continuous lenalidomide treatment for newly diagnosed multiple myelomaAntonio Palumbo, Roman Hajek, Michel Delforge, et al.
Blood|January 23, 2014
Inherited genetic susceptibility to monoclonal gammopathy of unknown significanceNiels Weinhold, David C Johnson, Andrew C Rawstron, et al.
Haematologica|September 24, 2016
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trialChristian Straka, Peter Liebisch, Hans Salwender, et al.
Nature Cancer|June 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesEvelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng, et al.
Nature Genetics|August 20, 2013
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma riskDaniel Chubb, Niels Weinhold, Peter Broderick, et al.
International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.
Nature Communications|July 2, 2016
Genome-wide association study identifies multiple susceptibility loci for multiple myelomaJonathan S Mitchell, Ni Li, Niels Weinhold, et al.
Nature Communications|September 15, 2018
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myelomaMolly Went, Amit Sud, Asta Försti, et al.
Pageof 8